Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Ze-min Han, Bing-xia Chen, Qian Zhou, Hong-bin Liu, Pei-chun Xu & Fa-chao Zhi. (2021) Predictors of infliximab-induced deep remission in treatment-naïve patients with isolated small bowel Crohn’s disease. Scandinavian Journal of Gastroenterology 56:12, pages 1422-1426.
Read now
Read now
Gil Y. Melmed, Dermot McGovern, Stefan Schreiber, Gordana Kosutic, Marshall Spearman, Jason Coarse & William J. Sandborn. (2016) Early remission status predicts long-term outcomes in patients with Crohn’s disease treated with certolizumab pegol. Current Medical Research and Opinion 32:12, pages 1937-1941.
Read now
Read now
Renata D’Incà & Roberta Caccaro. (2014) Measuring disease activity in Crohn’s disease: what is currently available to the clinician. Clinical and Experimental Gastroenterology 7, pages 151-161.
Read now
Read now
Tomohiko Sasaki, Reiko Kunisaki, Hiroto Kinoshita, Hisae Yamamoto, Hideaki Kimura, Akiho Hanzawa, Naomi Shibata, Hiromi Yonezawa, Eiji Miyajima, Kentaro Sakamaki, Kazushi Numata, Katsuaki Tanaka & Shin Maeda. (2014) Use of color Doppler ultrasonography for evaluating vascularity of small intestinal lesions in Crohn's disease: correlation with endoscopic and surgical macroscopic findings. Scandinavian Journal of Gastroenterology 49:3, pages 295-301.
Read now
Read now
Amon Asgharpour, Jianfeng Cheng & Stephen J Bickston. (2013) Adalimumab treatment in Crohn’s disease: an overview of long-term efficacy and safety in light of the EXTEND trial. Clinical and Experimental Gastroenterology 6, pages 153-160.
Read now
Read now
Articles from other publishers (48)
Lidia Neamți, Tudor Drugan, Cristina Drugan, Ciprian Silaghi, Lidia Ciobanu & Alexandra Crăciun. (2023) An Improved Score for the Evaluation of Mucosal Healing in Inflammatory Bowel Disease—A Pilot Study. Journal of Clinical Medicine 12:4, pages 1663.
Crossref
Crossref
Yajun Liu, Feiyan Tian, Shuijiao Chen & jiuye Hu. (2023) Improved comprehensive evaluation of Crohn’s disease activity by intestinal computed tomography enterography combined with endoscopy and biochemical indicators. Arab Journal of Gastroenterology 24:1, pages 16-23.
Crossref
Crossref
Zhigang Wang, Bram Verstockt, João Sabino, Séverine Vermeire, Marc Ferrante, Paul Declerck & Erwin Dreesen. (2021) Population pharmacokinetic‐pharmacodynamic model‐based exploration of alternative ustekinumab dosage regimens for patients with Crohn's disease. British Journal of Clinical Pharmacology 88:1, pages 323-335.
Crossref
Crossref
David Laharie, Geert D’Haens, Maria Nachury, Guy Lambrecht, Peter Bossuyt, Yoram Bouhnik, Edouard Louis, Christien Janneke van der Woude, Anthony Buisson, Philippe Van Hootegem, Matthieu Allez, Jérôme Filippi, Hedia Brixi, Cyrielle Gilletta, Laurence Picon, Filip Baert, Séverine Vermeire, Nicolas Duveau & Laurent Peyrin-Biroulet. (2021) Steroid-Free Deep Remission at One Year Does Not Prevent Crohn's Disease Progression: Long-Term Data From the TAILORIX Trial. Clinical Gastroenterology and Hepatology.
Crossref
Crossref
Nikolas Plevris, James Fulforth, Mathew Lyons, Spyros I. Siakavellas, Philip W. Jenkinson, Cher S. Chuah, Laura Lucaciu, Rebecca J. Pattenden, Ian D. Arnott, Gareth-Rhys Jones & Charlie W. Lees. (2021) Normalization of Fecal Calprotectin Within 12 Months of Diagnosis Is Associated With Reduced Risk of Disease Progression in Patients With Crohn’s Disease. Clinical Gastroenterology and Hepatology 19:9, pages 1835-1844.e6.
Crossref
Crossref
Christoph Kessel, Miha Lavric, Toni Weinhage, Markus Brueckner, Sytze de Roock, Jan Däbritz, Jakob Weber, Sebastiaan J. Vastert & Dirk Foell. (2021) Serum biomarkers confirming stable remission in inflammatory bowel disease. Scientific Reports 11:1.
Crossref
Crossref
Erwin Dreesen, Sophie Berends, David Laharie, Geert D'Haens, Séverine Vermeire, Ann Gils & Ron Mathôt. (2020) Modelling of the relationship between infliximab exposure, faecal calprotectin and endoscopic remission in patients with Crohn's disease. British Journal of Clinical Pharmacology 87:1, pages 106-118.
Crossref
Crossref
Jordi Rimola, Agnès Fernàndez-Clotet, Nunzia Capozzi, Sònia Rojas-Farreras, Ignacio Alfaro, Sonia Rodríguez, Maria-Carme Masamunt, Elena Ricart, Ingrid Ordás & Julian Panés. (2020) Pre-treatment magnetic resonance enterography findings predict the response to TNF-alpha inhibitors in Crohn's disease. Alimentary Pharmacology & Therapeutics.
Crossref
Crossref
Clara Yzet, Momar Diouf, Jean-Philippe Le Mouel, Franck Brazier, Justine Turpin, Julien Loreau, Jean Louis Dupas, Laurent Peyrin-Biroulet & Mathurin Fumery. (2020) Complete Endoscopic Healing Associated With Better Outcomes Than Partial Endoscopic Healing in Patients With Crohn’s Disease. Clinical Gastroenterology and Hepatology 18:10, pages 2256-2261.
Crossref
Crossref
Eran Zittan, Ian M. Gralnek & Marc S. Berns. (2020) The New Proactive Approach and Precision Medicine in Crohn’s Disease. Biomedicines 8:7, pages 193.
Crossref
Crossref
Geert D’Haens, Orlaith Kelly, Robert Battat, Mark S. Silverberg, David Laharie, Edouard Louis, Edoardo Savarino, Giorgia Bodini, Andres Yarur, Brigid S. Boland, Waqqas Afif, Xiao-jun Li, Michael Hale, Jessica Ho, Venkateswarlu Kondragunta, Benjamin Huang, Crystal Kuy, Lauren Okada, Kelly D. Hester, Kurtis R. Bray, Larry Mimms, Anjali Jain, Siddharth Singh, Angelina Collins, Mark A. Valasek, William J. Sandborn, Severine Vermeire & Parambir S. Dulai. (2020) Development and Validation of a Test to Monitor Endoscopic Activity in Patients With Crohn’s Disease Based on Serum Levels of Proteins. Gastroenterology 158:3, pages 515-526.e10.
Crossref
Crossref
Sonja Gordic, Octavia Bane, Shingo Kihira, Steven Peti, Stefanie Hectors, Joana Torres, Judy Cho, Jean-Frederic Colombel & Bachir Taouli. (2020) Evaluation of ileal Crohn’s disease response to TNF antagonists: Validation of MR enterography for assessing response. Initial results. European Journal of Radiology Open 7, pages 100217.
Crossref
Crossref
Sara Salvador-Martín, Beatriz López-Cauce, Olga Nuñez, Emilio J. Laserna-Mendieta, María I. García, Elena Lobato, Judith Abarca-Zabalía, María Sanjurjo-Saez, Alfredo J. Lucendo, Ignacio Marín-Jiménez, Luis A. Menchén & Luis A. López-Fernández. (2019) Genetic predictors of long-term response and trough levels of infliximab in crohn’s disease. Pharmacological Research 149, pages 104478.
Crossref
Crossref
Ting Feng, Baili Chen, Bella Ungar, Yun Qiu, Shenghong Zhang, Jinshen He, Sinan Lin, Yao He, Zhirong Zeng, Shomron Ben-Horin, Minhu Chen & Ren Mao. (2019) Association of Infliximab Levels With Mucosal Healing Is Time-Dependent in Crohn’s Disease: Higher Drug Exposure Is Required Postinduction Than During Maintenance Treatment. Inflammatory Bowel Diseases 25:11, pages 1813-1821.
Crossref
Crossref
Tereza Lerchova, Ondrej Hradsky, Ivana Copova, Kristyna Potuznikova, Lucie Gonsorcikova & Jiri Bronsky. (2019) The Accuracy of a Home-performed Faecal Calprotectin Test in Paediatric Patients With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology & Nutrition 69:1, pages 75-81.
Crossref
Crossref
Ignacio Alfaro, Maria Carme Masamunt, Nuria Planell, Alicia López-García, Jesús Castro, Marta Gallego, Rebeca Barastegui, Angel Giner, Alejandro Vara, Azucena Salas, Elena Ricart, Julián Panés & Ingrid Ordás. (2019) Endoscopic response to tumor necrosis factor inhibitors predicts long term benefits in Crohn’s disease. World Journal of Gastroenterology 25:14, pages 1764-1774.
Crossref
Crossref
Peter Bossuyt, Edouard Louis, Jean-Yves Mary, Séverine Vermeire & Yoram Bouhnik. (2018) Defining Endoscopic Remission in Ileocolonic Crohn’s Disease: Let’s Start from Scratch. Journal of Crohn's and Colitis 12:10, pages 1245-1248.
Crossref
Crossref
Amirkasra Mojtahed & Michael S. Gee. (2018) Magnetic resonance enterography evaluation of Crohn disease activity and mucosal healing in young patients. Pediatric Radiology 48:9, pages 1273-1279.
Crossref
Crossref
Philip E. Dubé, Cambrian Y. Liu, Nandini Girish, M. Kay Washington & D. Brent Polk. (2018) Pharmacological activation of epidermal growth factor receptor signaling inhibits colitis-associated cancer in mice. Scientific Reports 8:1.
Crossref
Crossref
A. Barré, J.-F. Colombel & R. Ungaro. (2018) Review article: predictors of response to vedolizumab and ustekinumab in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 47:7, pages 896-905.
Crossref
Crossref
Kenji Watanabe, Takayuki Matsumoto, Tadakazu Hisamatsu, Hiroshi Nakase, Satoshi Motoya, Naoki Yoshimura, Tetsuya Ishida, Shingo Kato, Tomoo Nakagawa, Motohiro Esaki, Masakazu Nagahori, Toshiyuki Matsui, Yuji Naito, Takanori Kanai, Yasuo Suzuki, Masanori Nojima, Mamoru Watanabe, Toshifumi Hibi, Akira Andoh, Toshifumi Ashida, Katsuya Endo, Yutaka Endo, Motohiro Esaki, Hiroshi Fujita, Mikihiro Fujiya, Ken Haruma, Toshifumi Hibi, Sakiko Hiraoka, Ichiro Hirata, Tadakazu Hisamatsu, Yutaka Honda, Hideki Iijima, Bunei Iizuka, Kentaro Ikeya, Takuya Inoue, Syuji Inoue, Tetsuya Ishida, Yo Ishiguro, Shyunji Ishihara, Hiroaki Ito, Ryuichi Iwakiri, Takashi Kagaya, Takanori Kanai, Hiroshi Kashida, Shingo Kato, Jun Kato, Takehiko Katsurada, Fukunori Kinjyo, Kiyonori Kobayashi, Mayumi Kodama, Reiko Kunisaki, Koichi Kurahara, Takafumi Kurokami, Lee Kyouwon, Koichiro Matsuda, Kazuhiro Matsueda, Toshiyuki Matsui, Takayuki Matsumoto, Keiichi Mitsuyama, Yuji Mizokami, Satoshi Motoya, Yuji Naito, Tomoo Nakagawa, Shiro Nakamura, Hiroshi Nakase, Masanori Nojima, Masafumi Nomura, Atsuhiro Ogawa, Kazuichi Okazaki, Kazuaki Otsuka, Hirotake Sakuraba, Masayuki Saruta, Makoto Sasaki, Takayuki Shirai, Tomoaki Suga, Kazuhito Sugimura, Toshiro Sugiyama, Yasuo Suzuki, Fuminao Takeshima, Hiroyuki Tamaki, Shinji Tanaka, Satoshi Tanida, Keiichi Tominaga, Taku Tomizawa, Kenji Watababe, Mamoru Watanabe, Kenji Watanabe, Syojiro Yamamoto, Masaki Yamashita, Atsushi Yoshida & Naoki Yoshimura. (2018) Clinical and Pharmacokinetic Factors Associated With Adalimumab-Induced Mucosal Healing in Patients With Crohn’s Disease. Clinical Gastroenterology and Hepatology 16:4, pages 542-549.e1.
Crossref
Crossref
M. A. Cozijnsen, J. N. Samsom & L. de Ridder. (2017) Anti-Tumour Necrosis Factor Therapy for Paediatric Crohn’s Disease: Improved Benefits Through Treatment Optimisation, Deeper Understanding of Its Risks, and Reduced Costs due to Biosimilar Availability. Pediatric Drugs 20:1, pages 19-28.
Crossref
Crossref
Jin-Min Chen, Tao Liu, Shan Gao, Xu-Dong Tong, Fei-Hong Deng & Biao Nie. (2017) Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China. World Journal of Gastroenterology 23:46, pages 8235-8247.
Crossref
Crossref
Loris Lopetuso, Viviana Gerardi, Valerio Papa, Franco Scaldaferri, Gian Rapaccini, Antonio Gasbarrini & Alfredo Papa. (2017) Can We Predict the Efficacy of Anti-TNF-α Agents?. International Journal of Molecular Sciences 18:9, pages 1973.
Crossref
Crossref
Savini L. Santha, Prabhu R. Shankar, Anqi Pan, Bess Schoen, Subra Kugathasan & Cary G. Sauer. (2017) Mucosal Healing in Clinical Practice. Inflammatory Bowel Diseases 23:8, pages 1447-1453.
Crossref
Crossref
Helga Bertani, Laurent Palazzo, Vincenzo Giorgio Mirante & Flavia Pigò. 2017. Diagnosis and Endoscopic Management of Digestive Diseases. Diagnosis and Endoscopic Management of Digestive Diseases
1
20
.
Ben Kang, So Yoon Choi, Hye Seung Kim, Kyunga Kim, Yoo Min Lee & Yon Ho Choe. (2016) Mucosal Healing in Paediatric Patients with Moderate-to-Severe Luminal Crohn’s Disease Under Combined Immunosuppression: Escalation versus Early Treatment. Journal of Crohn's and Colitis 10:11, pages 1279-1286.
Crossref
Crossref
Matthew P. MoyJess L. KaplanChristopher J. MoranHarland S. WinterMichael S. Gee. (2016) MR Enterographic Findings as Biomarkers of Mucosal Healing in Young Patients With Crohn Disease. American Journal of Roentgenology 207:4, pages 896-902.
Crossref
Crossref
Z. Grover, C. Burgess, R. Muir, C. Reilly & P. J. Lewindon. (2016) Early Mucosal Healing with Exclusive Enteral Nutrition is Associated with Improved Outcomes in Newly Diagnosed Children with Luminal Crohn’s disease. Journal of Crohn's and Colitis 10:10, pages 1159-1164.
Crossref
Crossref
Elena Dubcenco, Guangyong Zou, Larry Stitt, Jeffrey P. Baker, Khursheed N. Jeejeebhoy, Gabor Kandel, Young-in Kim, Samir C. Grover, John W. D. McDonald, Lisa M. Shackelton, Reena Khanna, Geert D’Haens, William J. Sandborn, Brian G. Feagan & Barrett G. Levesque. (2016) Effect of Standardised Scoring Conventions on Inter-rater Reliability in the Endoscopic Evaluation of Crohn’s Disease. Journal of Crohn's and Colitis 10:9, pages 1006-1014.
Crossref
Crossref
Andrew R. Reinink, Terrence C. Lee & Peter D. R. Higgins. (2016) Endoscopic Mucosal Healing Predicts Favorable Clinical Outcomes in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 22:8, pages 1859-1869.
Crossref
Crossref
Anton Shavrov, Anastasia Y. Kharitonova, Elisabeth M. Davis, Brian Claggett, Dmitriy A. Morozov, Daniel K. Brown, Andrey A. Shavrov & Julia J. Liu. (2016) A Pilot Study of Confocal Laser Endomicroscopy to Predict Barrier Dysfunction and Relapse in Pediatric Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology & Nutrition 62:6, pages 873-878.
Crossref
Crossref
Cary G. Sauer, Jeremy P. Middleton, Courtney McCracken, Jonathan Loewen, Kiery Braithwaite, Adina Alazraki, Diego R. Martin & Subra Kugathasan. (2016) Magnetic Resonance Enterography Healing and Magnetic Resonance Enterography Remission Predicts Improved Outcome in Pediatric Crohn Disease. Journal of Pediatric Gastroenterology & Nutrition 62:3, pages 378-383.
Crossref
Crossref
Caroline Meyer Olesen, Mehmet Coskun, Laurent Peyrin-Biroulet & Ole Haagen Nielsen. (2016) Mechanisms behind efficacy of tumor necrosis factor inhibitors in inflammatory bowel diseases. Pharmacology & Therapeutics 159, pages 110-119.
Crossref
Crossref
S. C. Shah, J.-F. Colombel, B. E. Sands & N. Narula. (2016) Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease. Alimentary Pharmacology & Therapeutics 43:3, pages 317-333.
Crossref
Crossref
Naoto Saigusa, Jun-ichi Saigusa, Tadashi Yokoyama, Takaaki Oosawa, Seiji Ishiguro, Masaru Shinozaki, Manabu Kikuchi & Yasuhisa Yokoyama. (2016) “Top Down Therapy” for Patients with Crohn's Disease who Initially Presented with Anorectal Fistula May Improve Perianal and Bowel Disease. Nippon Daicho Komonbyo Gakkai Zasshi 69:8, pages 424-429.
Crossref
Crossref
Matthew P. Moy, Jenny Sauk & Michael S. Gee. (2016) The Role of MR Enterography in Assessing Crohn’s Disease Activity and Treatment Response. Gastroenterology Research and Practice 2016, pages 1-13.
Crossref
Crossref
Parakkal Deepak & David H. Bruining. (2015) Update on the Medical Management of Crohn’s Disease. Current Gastroenterology Reports 17:11.
Crossref
Crossref
Uri Kopylov, Doron Yablecovitch, Adi Lahat, Sandra Neuman, Nina Levhar, Tomer Greener, Eyal Klang, Noa Rozendorn, Marianne M Amitai, Shomron Ben-Horin & Rami Eliakim. (2015) Detection of Small Bowel Mucosal Healing and Deep Remission in Patients With Known Small Bowel Crohn’s Disease Using Biomarkers, Capsule Endoscopy, and Imaging. American Journal of Gastroenterology 110:9, pages 1316-1323.
Crossref
Crossref
Kazuhiro Morise. (2015) Clinical utility of a new endoscopic scoring system for Crohn’s disease. World Journal of Gastroenterology 21:34, pages 9974.
Crossref
Crossref
Barry Hall, Grainne Holleran & Deirdre McNamara. (2015) Small Bowel Crohn's Disease: An Emerging Disease Phenotype?. Digestive Diseases 33:1, pages 42-51.
Crossref
Crossref
Barry Hall, Grainne Holleran, Jun-Liong Chin, Sinead Smith, Barbara Ryan, Nasir Mahmud & Deirdre McNamara. (2014) A prospective 52week mucosal healing assessment of small bowel Crohn's disease as detected by capsule endoscopy. Journal of Crohn's and Colitis 8:12, pages 1601-1609.
Crossref
Crossref
Barry J. Hall, Grainne E. Holleran, Sinead M. Smith, Nasir Mahmud & Deirdre A. McNamara. (2014) A prospective 12-week mucosal healing assessment of small bowel Crohn’s disease as detected by capsule endoscopy. European Journal of Gastroenterology & Hepatology 26:11, pages 1253-1259.
Crossref
Crossref
Marta Sobczak, Adam Fabisiak, Natalia Murawska, Ewelina Wesołowska, Paulina Wierzbicka, Marcin Wlazłowski, Marta Wójcikowska, Hubert Zatorski, Marta Zwolińska & Jakub Fichna. (2014) Current overview of extrinsic and intrinsic factors in etiology and progression of inflammatory bowel diseases. Pharmacological Reports 66:5, pages 766-775.
Crossref
Crossref
Pauliina Molander, Martti Färkkilä, Ari Ristimäki, Kimmo Salminen, Helena Kemppainen, Timo Blomster, Ritva Koskela, Airi Jussila, Henna Rautiainen, Markku Nissinen, Johanna Haapamäki, Perttu Arkkila, Urpo Nieminen, Juha Kuisma, Jari Punkkinen, Kaija-Leena Kolho, Harri Mustonen & Taina Sipponen. (2014) Does fecal calprotectin predict short-term relapse after stopping TNFα-blocking agents in inflammatory bowel disease patients in deep remission?. Journal of Crohn's and Colitis.
Crossref
Crossref
Byron P. Vaughn, Sveta Shah & Adam S. Cheifetz. (2014) The Role of Mucosal Healing in the Treatment of Patients With Inflammatory Bowel Disease. Current Treatment Options in Gastroenterology 12:1, pages 103-117.
Crossref
Crossref
Ingrid Ordás, Jordi Rimola, Sonia Rodríguez, José M. Paredes, María J. Martínez-Pérez, Esther Blanc, Juan A. Arévalo, Marta Aduna, Montserrat Andreu, Alexander Radosevic, Anna M. Ramírez-Morros, Susana Pinó, Marta Gallego, Aranzazu Jauregui-Amezaga, Elena Ricart & Julián Panés. (2014) Accuracy of Magnetic Resonance Enterography in Assessing Response to Therapy and Mucosal Healing in Patients With Crohn's Disease. Gastroenterology 146:2, pages 374-382.e1.
Crossref
Crossref
Mark R. Frey & D. Brent Polk. (2013) ErbB receptors and their growth factor ligands in pediatric intestinal inflammation. Pediatric Research 75:1-2, pages 127-132.
Crossref
Crossref